BioCentury
ARTICLE | Top Story

Supernus raises $48 million in follow-on

December 1, 2012 2:33 AM UTC

Supernus Pharmaceuticals Inc. (NASDAQ:SUPN) raised $48 million through the sale of 6 million shares at $8 in a follow-on underwritten by Jefferies; Piper Jaffray; Cowen; Stifel Nicolaus Weisel; and Lazard. Supernus proposed to raise up to $86.3 million in a follow-on on Nov. 14, when its share price was $11.54. On Friday, Supernus was off $1.84 (19%) to $7.99. ...